Alternatives to AbCellera

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Alvox Bio is a life sciences startup developing novel therapeutic antibodies.

Leveraging the adaptive immune system to diagnose and treat disease.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

Biotech company focused on designing and developing novel biological solutions.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-powered drug discovery and development platform for biologics.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Advance every cancer decision.

Mining biological information for transformative peptide medicines.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Global marketplace connecting researchers with human biospecimens for life science research.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for designing novel molecular structures for new medicines.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Biotechnology company

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Enveda Biosciences is a biotechnology company using AI and metabolomics to discover new medicines from natural sources.

AI-powered platform accelerating biological research and drug discovery.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.